SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹241 Cr | ₹248 Cr | ₹52 Cr | ₹9.88 Cr |
What is the latest Total Current Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹248 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹9.88 Cr |
How is Total Current Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -2.75 | |
| Mar2024 | ₹248 Cr | 377.03 | |
| Mar2023 | ₹52 Cr | 424.92 | |
| Mar2022 | ₹9.88 Cr | - | |
Compare Total Current Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,872.4 Cr | 12.2% | 2.8% | 118.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 12.2% |
2.8% |
118.1% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses